Differential muscle gene expression as a function of disease progression in Goto-Kakizaki diabetic rats

Molecular and Cellular Endocrinology

Volumn 338, Issue 1-2, 2011, Pages 10-17

  Nie, Jing ^a   Xue, Bai ^a   Sukumaran, Siddharth ^a   Jusko, William J ^a   DuBois, Debra C ^a   Almon, Richard R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Gene expression; Inflammation; Microarrays; Skeletal muscle; Type 2 diabetes

Indexed keywords

INSULIN; LIPID;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETOGENESIS; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC VARIABILITY; GOTO KAKIZAKI RAT; HORMONE BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STRAIN DIFFERENCE; WISTAR KYOTO RAT;

ANIMALS; BLOOD CELL COUNT; BLOOD GLUCOSE; BODY WEIGHTS AND MEASURES; DIABETES MELLITUS, EXPERIMENTAL; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION PROFILING; GENES; INFLAMMATION; INSULIN; MALE; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; RATS; RATS, INBRED WKY; RATS, TRANSGENIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79955538502     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2011.02.016     Document Type: Article

References (34)

1. Abate N., Chandalia M., Satija P., Adams-Huet B., Grundy S.M., Sandeep S., Radha V., Deepa R., Mohan V. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to Type 2 diabetes. Diabetes 2005, 54:1207-1213.
2. Almon R.R., DuBois D.C., Lai W., Xue B., Nie J., Jusko W.J. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J. Endocrinol. 2009, 200:331-346.
3. Almon R.R., DuBois D.C., Yao Z., Hoffman E.P., Ghimbovschi S., Jusko W.J. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol. Genomics 2007, 30:282-299.
4. Bergman R.N., Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 2000, 11:351-356.
5. Bisbis S., Bailbe D., Tormo M.A., Picarel-Blanchot F., Derouet M., Simon J., Portha B. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am. J. Physiol. 1993, 265:E807-E813.
6. Bitar M.S., Al-Saleh E., Al-Mulla F. Oxidative stress - mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci. 2005, 77:2552-2573.
7. Brunetti P. The lean patient with type 2 diabetes: characteristics and therapy challenge. Int. J. Clin. Pract. Suppl. 2007, 3-9.
8. Cacho J., Sevillano J., de Castro J., Herrera E., Ramos M.P. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1269-E1276.
9. Copp S.W., Hageman K.S., Behnke B.J., Poole D.C., Musch T.I. Effects of Type II diabetes on exercising skeletal muscle blood flow in the rat. J. Appl. Physiol. 2011, 109:1347-1353.
10. Dadke S.S., Li H.C., Kusari A.B., Begum N., Kusari J. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats. Biochem. Biophys. Res. Commun. 2000, 274:583-589.
11. Ding J., Du K. ClipR-59 interacts with Akt and regulates Akt cellular compartmentalization. Mol. Cell. Biol. 2009, 29:1459-1471.
12. Frangioudakis G., Cooney G.J. Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling. J. Endocrinol. 2008, 197:277-285.
13. Goldfine I.D., Maddux B.A., Youngren J.F., Reaven G., Accili D., Trischitta V., Vigneri R., Frittitta L. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr. Rev. 2008, 29:62-75.
14. Goto Y., Suzuki K., Ono T., Sasaki M., Toyota T. Development of diabetes in the non-obese NIDDM rat (GK rat). Adv. Exp. Med. Biol. 1988, 246:29-31.
15. Hundal R.S., Krssak M., Dufour S., Laurent D., Lebon V., Chandramouli V., Inzucchi S.E., Schumann W.C., Petersen K.F., Landau B.R., Shulman G.I. Mechanism by which metaformin reduces glucose production in type 2 diabetes. Diabetes 2000, 49:2063-2069.
16. Kanoh Y., Bandyopadhyay G., Sajan M.P., Standaert M.L., Farese R.V. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats. Endocrinology 2001, 142:1595-1605.
17. Koistinen H.A., Zierath J.R. Regulation of glucose transport in human skeletal muscle. Ann. Med. 2002, 34:410-418.
18. Krook A., Kawano Y., Song X.M., Efendic S., Roth R.A., Wallberg-Henriksson H., Zierath J.R. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997, 46:2110-2114.
19. Maddux B.A., Chang Y.-N., Accili D., McGuinness O.P., Youngren J.F., Goldfine I.D. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E746-E749.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
21. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
22. Moxley R.T., Griggs R.C., Goldblatt D., VanGelder V., Herr B.E., Thiel R. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J. Clin. Invest. 1978, 62:857-867.
23. Mulvey C., Harno E., Keenan A., Ohlendieck K. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. Eur. J. Cell Biol. 2005, 84:867-883.
24. Padilla D.J., McDonough P., Behnke B.J., Kano Y., Hageman K.S., Musch T.I., Poole D.C. Effects of Type II diabetes on capillary hemodynamics in skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2439-H2444.
25. Padilla D.J., McDonough P., Behnke B.J., Kano Y., Hageman K.S., Musch T.I., Poole D.C. Effects of Type II diabetes on muscle microvascular oxygen pressures. Respir. Physiol. Neurobiol. 2007, 156:187-195.
26. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8466-8471.
27. Portha B. Programmed disorders of B-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabet. Metabol. Res. Rev. 2005, 21:495-504.
28. Rome S., Clement K., Rabasa-Lhoret R., Loizon E., Poitou C., Barsh G.S., Riou J.-P., Laville M., Vidal H. Microarray profiling of human skeletal muscle reveals that insulin regulates ~800 genes during a hyperinsulinemic clamp. J. Biol. Chem. 2003, 278:18063-18068.
29. Steiler T.L., Galuska D., Leng Y., Chibalin A.V., Gilbert M., Zierath J.R. Effect of hyperglycemia on signal transduction in skeletal muscle from diabetic Goto-Kakizaki rats. Endocrinology 2003, 144:5259-5267.
30. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
31. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
32. Yasuda K., Nishikawa W., Iwanaka N., Nakamura E., Seino Y., Tsuda K., Ishihara A. Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto-Kakizaki rats. Clin. Exp. Pharmacol. Physiol. 2002, 29:1001-1008.
33. Yuan J. Modeling blood/plasma concentrations in dosed feed and dosed drinking water toxicology studies. Toxicol. Appl. Pharmacol. 1993, 119:131-141.
34. Zhou H.H., Chin C.-N., Wu M., Ni W., Quan S., Liu F., Dallas-Yang Q., Ellsworth K., Ho T., Zhang A., Natasha T., Li J., Chapman K., Strohl W., Li C., Wang I.-M., Berger J., An Z., Zhang B.B., Jiang G. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur. J. Pharmacol. 2009, 616:346-352.